Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab
28 Mar 2025
bởiStephen Padilla
The use of lebrikizumab improves the symptoms of moderate-to-severe atopic dermatitis (AD) in patients previously treated with dupilumab, reports a study presented at AAD 2025.
Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab
28 Mar 2025
Eyebrow or eyelash hair loss affects QoL in AA patients
25 Mar 2025
bởiAudrey Abella
A real-world analysis presented at AAD 2025 shows that patients with alopecia areata (AA) with eyebrow or eyelash hair loss have greater health-related quality of life (HRQoL) burden than those without eyebrow and eyelash involvement.
Eyebrow or eyelash hair loss affects QoL in AA patients
25 Mar 2025
Composite metric boosts tapinarof efficacy for AD
20 Mar 2025
bởiAudrey Abella
Two pivotal phase III trials show that a once-daily application of tapinarof cream 1% yields rapid treatment response – as indicated by the vIGA-AD™×BSA* composite score – in individuals with moderate-to-severe atopic dermatitis (AD).